Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker

Abstract This paper describes direct label-free detection of 17beta-hydroxysteroid dehydrogenase type 10 (17β-HSD10) using a surface plasmon resonance (SPR) biosensor. This multifunctional mitochondrial enzyme is involved in pathogenesis of Alzheimer disease (AD) and represents a potential target for AD diagnostics. A multichannel SPR sensor with spectral modulation is functionalized with amyloid beta or polyclonal antibody against 17β-HSD10 peptide using a self-assembled monolayer of alkylthiolates and amino coupling chemistry. Detection of a synthetic peptide of 14 amino acids from the 17β-HSD10 molecule (residues 133–146 aa) and whole enzyme 17β-HSD10 is performed. Detection of 17β-HSD10 enzyme in artificial cerebrospinal fluid (ACSF) buffer is also carried out. It is demonstrated that the reported SPR biosensor is capable of detecting 17β-HSD10 enzyme at ng/ml levels.

[1]  Avraham Rasooly,et al.  Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk. , 2002, International journal of food microbiology.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[3]  J. Homola.  Surface plasmon resonance sensors for detection of chemical and biological species. , 2008, Chemical reviews.

[4]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[5]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[6]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[7]  G. Belfort,et al.  Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction. , 2007, Biochemistry.

[8]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[9]  Song-Yu Yang,et al.  A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[10]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[11]  G. Hajak,et al.  Cerebrospinal fluid tau and β-amyloid in Alzheimer patients, disease controls and an age-matched random sample , 2006, Neurobiology of Aging.

[12]  R. Rich,et al.  Molecular basis for passive immunotherapy of Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.

[13]  G M Whitesides,et al.  A strategy for the generation of surfaces presenting ligands for studies of binding based on an active ester as a common reactive intermediate: a surface plasmon resonance study. , 1999, Analytical chemistry.

[14]  Marek Piliarik,et al.  Data analysis for optical sensors based on spectroscopy of surface plasmons , 2002 .

[15]  D. Small,et al.  Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in alzheimer’s disease research , 2009, Neurotoxicity Research.